Important pharmacokinetic parameters are:
AUC: Area under the concentration–time curve. It is a measure of the extent of
Cmax: It is the observed maximum concentration of a drug. It is a measure of rate and
max: It is the time at which Cmax is observed. It is a measure of the rate of absorption.
Types of bioequivalence studies (Figs 9.8 and 9.9)
Fig. 9.8: Types of bioequivalence studies
Fig. 9.9: Types of in vivo bioequivalence studies
Biowavers are the exemptions that are granted by USFDA from conducting human
bioequivalence studies. Biowavers reduce the need for bioequivalence studies. They
are given when in vitro studies data provides sufficient estimate of a relative in vivo
performance of two products. These are given when API meets certain solubility and
permeability criteria. Biowavers are given in case if:
i. Drugs are highly soluble and highly permeable.
ii. Highest dose strength of the drug is soluble in 250 ml aqueous solution over a
iii. 90% of the drug is absorbed if administered orally.
iv. 80% of the drug is absorbed within 15 min of administration at 37°C.
v. Clinical research protocols
Bioequivalence studies are not required in case of:
i. Drugs are parenterally administered
iv. The new drug has a high therapeutic window.
v. Drugs with rapid and similar dissolution.
9.5 BIOSTATISTICS IN PHARMACEUTICAL PRODUCT DEVELOPMENT
Statistics is the science which deals with collection, tabulation and classification of
numerical facts as the basis for explanation, description and comparison of the
Biostatistics is the branch of statistics concerned with mathematical facts and data
related to biological events. Sir Francis Galton is the Father of biostatistics.
There are two types of biostatistics
1. Inferential biostatistics: It is the methods of generalising a larger group. The
generalization is based on information about a sample. The sample is considered to
2. Descriptive biostatistics: These are used to explain the basic features of the data.
No comments:
Post a Comment
اكتب تعليق حول الموضوع